Atlas Trials

Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

Clinical trial NCT07689188 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07689188
Sponsor
Harrison Dermatology
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa (HS)
Start date
2026-08-10
Primary completion
2028-03-10
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.